Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Deciphera Pharmaceuticals, Inc. (DCPH)
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
deciphera.com/investor-relations
Company Research
Source: Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Tuesday, April 16, 2024 at 11:30 AM ET.A live webcast of the fireside chat will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.About Deciphera PharmaceuticalsDeciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and
Show less
Read more
Impact Snapshot
Event Time:
DCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCPH alerts
High impacting Deciphera Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
DCPH
News
- Janux Therapeutics jumps as much as 28% on heels of Deciphera buyout deal [Seeking Alpha]Seeking Alpha
- Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday? [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, HCPPR Newswire
- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $25.60 price target on the stock, down previously from $26.00.MarketBeat
- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jonestrading. They now have a $25.60 price target on the stock.MarketBeat
DCPH
Earnings
- 2/6/24 - Beat
DCPH
Sec Filings
- 4/29/24 - Form 8-K
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- DCPH's page on the SEC website